Public Health Policy
-
Introduction Public health developed as a discipline to investigate the determinants of health at the population level. Winslow’s classic definition frames it as “the science and art of preventing disease, prolonging life, and promoting physical health and…
-
Abstract This paper examines critical safety issues of mRNA lipid nanoparticle formulations (hereinafter referred to as genetic vaccines and mRNA vaccines) for coronavirus disease 2019 (COVID-19)— including Comirnaty (development code BNT162b2), Spikevax (development code mRNA-1273), and Kostaive…
-
Abstract The time trend in the cognitive ability of U.S. children identified with autism spectrum disorder (ASD) was systematically tracked for the first time from birth year 1992 to 2014 using data from the Autism and Developmental…
-
Abstract Autism Spectrum Disorders (ASD) encompass a range of neurodevelopmental conditions defined by behavioral criteria, which provide no insight into the underlying pathophysiology linking vaccines and infections to observed pathological changes. For a considerable time, the debate…
-
Abstract Background: Millions of individuals have reported adverse events (AEs) using the U.S. Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System (VAERS) in the context of the COVID-19 injectable products. Tens of thousands have reported…
-
Abstract Background: Millions of individuals in the United States have reported adverse events (AEs) using the Vaccine Adverse Event Reports System (VAERS) since the roll-out of the COVID-19 injections in 2021. Methods: VAERS data was used to…
-
Abstract There are likely but hitherto unreported safety signals for GardasilTM vaccine in the form of increased risk of suicides and deaths from all causes in clinical trial group exposed to the Gardasil vaccine. Comparison of suicide…
-
Abstract Mental Health policy in America should address the growing need to help people live the happiest and best life possible, and support them in getting there. Recovery from mental health issues is founded on the principle…
Editor’s Choice
-
Evidence-Based Evaluation of PCR Diagnostics for SARS-CoV-2 and the Omicron Variants by Gold Standard Sanger Sequencing
-
A Report on the U.S. Vaccine Adverse Events Reporting System (VAERS) of the COVID-19 Messenger Ribonucleic Acid (mRNA) Biologicals
-
Significant Under-Reporting of Quadrivalent Human Papillomavirus Vaccine-Associated Serious Adverse Events in the United States: Time for Change?
About the Journal
This initiative exists to help insure that policies in public health practice and law are founded on a full consideration of available knowledge derived by robust science. From Dr Lyons-Weiler: “While IPAK will continue to conduct basic, clinical and translational biomedical research in a completely unbiased manner, and will pubish results regardless of the outcome, it will also be increasingly centered on questions of policy and law that impact public health, laws that impact public health, and cases and rulings that impact the citizen’s expression of self-governance through law. We’re putting the Public back into Public Health.”
Most Read
-
Mandates and Lack of Transparency on COVID-19 Vaccine Safety has Fueled Distrust – An Apology to Patients is Long Overdue
-
Assessing Iodine Deficiency and Halide Levels in Brevard County, Florida: A Retrospective Practice Audit
-
Regulatory and Safety Assessment of COVID-19 mRNA-LNP Genetic Vaccines in Japan: Evidence for Revocation of Approval and Market Withdrawal







